Industry News

1. 9 Drugs Granted Fast Track By FDA's Voucher Program 10/23/2025

   With targets like pancreatic cancer, deafness, blindness, infertility and vaping addiction, these drugs were chosen due to an unmet need, addressing a public health crisis, boosting domestic manufacturing or increasing affordability.

2. Leaders In The Excipient Market: Region And Type 10/21/2025

   Though North America led the market with a 38.32% market share of $3.15 billion in 2024, Asia Pacific is expected to have the fastest growth in the upcoming years.

3. Pfizer Strengthens Obesity Foothold With Metsera Acquisition 9/22/2025

   After discouraging efforts to bring two oral obesity drugs to market—danuglipron and lotiglipron—this acquisition launches Pfizer back into the obesity therapeutic game.

4. FDA Cracks Down On GLP-1 Imports 9/11/2025

   GLP-1 bulk drug substances must be detained without physical examination (DWPE) unless they are on a list (Green List) of approved foreign GLP-1 manufacturers.

5. Oregon Court Upholds Drug Price Transparency Law 9/9/2025

   The law was first enacted in 2018, followed by a lawsuit by Pharmaceutical Research and Manufacturers of America (PhRMA) in 2019, claiming an infringement of free speech for pharmaceutical companies and violation of public property. PhRMA asked the court to bar Oregon from enforcing the law.

6. Spray Drying Market Poised To Nearly Double By 2033 9/2/2025

   The growth of the spray drying market is attributed to demand for enhanced stability, bioavailability and solubility of poorly soluble drugs.

7. AbbVie Enters Psychedelic Market With Bretisilocin Acquisition 8/28/2025

   Bretisilocin is a next-generation psychedelic compound (5-HT2A receptor agonist and 5-HT releaser) designed to exert a shorter duration of psychoactive experience, while retaining an extended therapeutic benefit

8. J&J Commits $2 Billion To N.C. Manufacturing Facility 8/21/2025

   J&J’s latest announcement follows its commitment in March to invest $55 billion to support U.S. manufacturing, R&D, and technology over the next four years.

9. FDA Launches PreCheck Program 8/12/2025

   The program introduces a two-phase approach to enable new U.S. drug manufacturing facilities: The Facility Readiness Phase and the Application Submission Phase.

10. President Trump Demands MFN Prices In Manufacturer Letters 8/7/2025

    President Trump has sent out a letter to 17 major pharmaceutical manufacturers, asking them to commit to lower prices by Sept. 29, 2025, or he plans to deploy every tool in his arsenal to protect American families.